Sun. Nov 17th, 2024

As AIDS2022 in Montreal comes to a close, UNAIDS Executive Director Winnie Byanyima said:

“Thanks to the dedication of thousands of scientists around the world, the determined organizing of civil society groups, and the support of key policy makers, the issues lifted up at AIDS2022 could enable a turning point in the global AIDS response. The new UNAIDS report released at the conference, In Danger, shows how the AIDS response has been blown off course, making action urgent.

The research presented at this conference provides new data, important scientific progress, and further evidence on the biomedical, social, and policy interventions needed to stop the AIDS pandemic. The insights and data shared by community organizations showed concretely how we can stop AIDS from snatching a life every minute and ways to tackle the inequalities driving the AIDS pandemic.

We are deeply saddened by how many researchers, officials, and people living with HIV from Africa, Asia, and Latin America were unable to come to the conference in Canada because they were unable to secure a visa. The host country of the next global AIDS conference, two years from now, must be one that guarantees that this will not be repeated and that those most affected by HIV can be fully at this important table.

Important steps forward were taken in Montreal.

This was a breakthrough conference for new long-acting ARVs to stop HIV. New research showed that injectable PrEP is among the most effective tools for preventing HIV available and that it works well in multiple populations. The World Health Organization released new guidelines and drugmaker ViiV has announced licenses for generic manufacturing of the drug in 90 countries. This could be a game changer if ViiV can provide an affordable price for low- and middle-income countries now, in the tens of dollars not hundreds of dollars, since it will be several years before generic production comes online and if generics are made available beyond these original 90 countries.